PGI Study: Oral Bacteria May Reduce Nicotine Dependence in Smokeless Tobacco Users
Oral Bacteria Could Help Smokeless Tobacco Users Quit: PGI

A groundbreaking study from the Postgraduate Institute of Medical Education and Research (PGIMER) has uncovered a surprising biological adaptation in the mouths of smokeless tobacco users. The research suggests that prolonged tobacco use may trigger the growth of specific oral bacteria capable of breaking down nicotine, a discovery that could pave the way for innovative tobacco cessation strategies.

The Science Behind Bacterial Adaptation

Conducted by the Department of Public Health Dentistry, the study delves into how repeated exposure to nicotine alters the oral microbiome. Researchers, led by Dr. Nishant Mehta, Associate Professor in the Unit of Public Health Dentistry at PGIMER's Oral Health Sciences Centre in Chandigarh, found that continuous contact with nicotine creates a selective environment. This environment encourages the proliferation of 'nicotinophilic' bacteria—microorganisms that can utilize nicotine as an energy source.

The study explains that while tobacco exposure is known to cause microbial dysbiosis (an imbalance in oral microbes) and damage teeth and gums, it can also lead to this functional adaptation. To investigate, the team collected saliva samples from smokeless tobacco users. They employed advanced techniques like 16S rRNA gene sequencing and MALDI-TOF mass spectrometry to identify microbial shifts at genetic and species levels.

From Discovery to Potential Application

Using culture-based methods, researchers isolated bacterial strains that could survive in nicotine-rich settings. These strains were then cultured in media containing nicotine, and their ability to degrade the compound was assessed through UV-visible spectroscopy. The results were clear: these microbes actively metabolized nicotine, breaking it down rather than merely tolerating it.

This biological process holds significant implications for public health, particularly in India where smokeless tobacco use is widespread and a major contributor to oral cancers and periodontal disease. The logic is compelling: if nicotine is broken down more rapidly in the mouth, the intensity and duration of its exposure in the body could decrease. This reduction may, in turn, lower nicotine dependence and cravings, offering a natural mechanism to support quitting efforts.

A New Frontier in Tobacco Cessation

The findings, which earned Dr. Mehta the Best Paper Award at the 29th IAPHD National Conference (NATCON 2025) in Mangaluru, underscore the need to look beyond conventional cessation methods like behavioral counseling and pharmacological aids. Researchers propose that understanding this microbial response could lead to the development of microbiome-based interventions.

Potential future applications include targeted oral probiotics or adjunct therapies designed to enhance this natural nicotine-degrading process. Such tools would work in harmony with the body's own biology, offering a novel approach to a persistent public health challenge.

While scientists caution that more research and clinical trials are necessary before these approaches can become mainstream treatments, they describe the PGIMER study as a promising and early step. It opens a new scientific perspective on addiction biology, suggesting that the answer to combating tobacco dependence might, in part, lie within the complex ecosystem of our own mouths.